Benzinga - Mon, 08 Feb 2021 17:36:59 -0400
Benzinga - Mon, 01 Feb 2021 14:29:06 -0400
Benzinga - Mon, 01 Feb 2021 11:00:03 -0400
Benzinga - Mon, 01 Feb 2021 10:26:27 -0400
Benzinga - Mon, 01 Feb 2021 10:20:01 -0400
Benzinga - Wed, 27 Jan 2021 06:10:49 -0400
Benzinga - Tue, 26 Jan 2021 13:48:12 -0400
Benzinga - Tue, 26 Jan 2021 13:29:11 -0400
Benzinga - Tue, 26 Jan 2021 06:15:25 -0400
Benzinga - Mon, 25 Jan 2021 14:40:20 -0400
Benzinga - Tue, 19 Jan 2021 10:17:47 -0400
Benzinga - Wed, 13 Jan 2021 06:14:36 -0400
Benzinga - Tue, 12 Jan 2021 13:05:23 -0400
Benzinga - Tue, 12 Jan 2021 10:12:11 -0400
Benzinga - Mon, 11 Jan 2021 06:11:55 -0400
load more
Sector: Health Care.Industry: Biotechnology
Capricor Therapeutics Inc is a United State-based clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, and other medical conditions. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 that is in Phase II clinical trials; and CAP-2003, which is in pre-clinical development for the treatment of certain cardiac and inflammatory conditions.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-13
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-11
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CAPRCapricor Therapeutics5.53%109.2M

Capricor Therapeutics Company Questions & Answers

Q

How do I buy Capricor Therapeutics (CAPR) stock?

A

You can purchase shares of Capricor Therapeutics (NASDAQ: CAPR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Capricor Therapeutics's (CAPR) main competitors?

A

Other companies in Capricor Therapeutics’s space includes: Cleveland BioLabs (NASDAQ:CBLI), Celyad Oncology (NASDAQ:CYAD) and Cellectar Biosciences (NASDAQ:CLRB).

Q

What is the target price for Capricor Therapeutics?

A

The latest price target for Capricor Therapeutics (NASDAQ: CAPR) was reported by H.C. Wainwright on 2019-07-15. The analyst firm set a price target for 12.40 expecting CAPR to rise to within 12 months (a possible 132.21% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Capricor Therapeutics (CAPR) stock ?

A

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $5.34 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Capricor Therapeutics (CAPR) dividend?

A

There are no upcoming dividends for Capricor Therapeutics.

Q

When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?

A
Capricor Therapeutics’s Q1 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for CAPR?

A

There is no upcoming split for Capricor Therapeutics.